CA2262469A1 - Uses for wnt polypeptides - Google Patents

Uses for wnt polypeptides

Info

Publication number
CA2262469A1
CA2262469A1 CA002262469A CA2262469A CA2262469A1 CA 2262469 A1 CA2262469 A1 CA 2262469A1 CA 002262469 A CA002262469 A CA 002262469A CA 2262469 A CA2262469 A CA 2262469A CA 2262469 A1 CA2262469 A1 CA 2262469A1
Authority
CA
Canada
Prior art keywords
wnt polypeptides
wnt
polypeptides
hematopoiesis
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002262469A
Other languages
French (fr)
Other versions
CA2262469C (en
Inventor
William Matthews
Timothy W. Austin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/696,566 external-priority patent/US5851984A/en
Application filed by Individual filed Critical Individual
Publication of CA2262469A1 publication Critical patent/CA2262469A1/en
Application granted granted Critical
Publication of CA2262469C publication Critical patent/CA2262469C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Uses for Wnt polypeptides in hematopoiesis are disclosed. In particular, in vitro and in vivo methods for enhancing proliferation, differentiation or maintenance of a hematopoietic stem/progenitor cell using a Wnt polypeptide, and optionally another cytokine, are described.
CA002262469A 1996-08-16 1997-08-07 Uses for wnt polypeptides Expired - Lifetime CA2262469C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/696,566 1996-08-16
US08/696,566 US5851984A (en) 1996-08-16 1996-08-16 Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
PCT/US1997/013910 WO1998006747A2 (en) 1996-08-16 1997-08-07 Uses for wnt polypeptides

Publications (2)

Publication Number Publication Date
CA2262469A1 true CA2262469A1 (en) 1998-02-19
CA2262469C CA2262469C (en) 2005-11-22

Family

ID=35475126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002262469A Expired - Lifetime CA2262469C (en) 1996-08-16 1997-08-07 Uses for wnt polypeptides

Country Status (1)

Country Link
CA (1) CA2262469C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3407907A4 (en) * 2016-01-28 2019-09-04 The Board of Trustees of the Leland Stanford Junior University Wnt compositions and methods for serum-free synthesis
EP3824885A1 (en) * 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824885A1 (en) * 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration
EP3407907A4 (en) * 2016-01-28 2019-09-04 The Board of Trustees of the Leland Stanford Junior University Wnt compositions and methods for serum-free synthesis

Also Published As

Publication number Publication date
CA2262469C (en) 2005-11-22

Similar Documents

Publication Publication Date Title
IL128129A0 (en) Uses of wnt polypeptides
CA2198603A1 (en) Use of Stem Cell Factor and Soluble Interleukin-6 Receptor for the Ex Vivo Expansion of Hematopoietic Multipotential Cells
EP1398370A3 (en) In-vitro micro-organs
IL142094A0 (en) Methods of controlling proliferation and differentiation of stem and progenitor cells
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
CA2267668A1 (en) Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide
CA2186747A1 (en) Interleukin-15
HUP9800901A3 (en) Process, medium and cell culture system for the preparation of recombinant factor viii in a protein free medium
EP0953041A4 (en) Serum-free mammalian cell culture medium, and uses thereof
AU8128094A (en) (in vitro) amplification of stem cells
AU4323599A (en) Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
PL336470A1 (en) Mammalian cytokin-like factor 7
CA2058019A1 (en) Use of pairs of peptides with extremely high specific affinity for one another in the area of in vitro diagnosis
AU3494397A (en) Fibroblast growth factor receptor activating gene i and related compositions and methods
AU3392697A (en) (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
WO2000015798A3 (en) Mammalian transforming growth factor beta - 9 (ztgfss9)
AU1706399A (en) Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
YU41798A (en) Scf analogous compositions and methods
CA2262469A1 (en) Uses for wnt polypeptides
AU1301797A (en) Polypeptides with interleukin 16 activity, process for the preparation and use thereof
HUP9801438A3 (en) Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
AU4030997A (en) Hematopoietic stem cell growth factor (scgf)
AU3068089A (en) Bovine embryo in vitro culture
AU5370998A (en) High purity mast cells and basophils and methods for (in vitro) differentiation thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170807